Sign up to save your podcasts
Or
Share First ever CRISPR gene therapy approval: What happens next?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First ever CRISPR gene therapy approval: What happens next?
Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?
Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.
Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.
View all episodes
By BioSpace
4.9
1313 ratings
Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?
Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.
Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.
More shows like BioSpace
View all
This American Life
90,994 Listeners
Planet Money
30,666 Listeners
Hidden Brain
43,528 Listeners
Marketplace
8,776 Listeners
Exchanges
970 Listeners
WSJ What’s News
4,345 Listeners
Bloomberg Surveillance
1,170 Listeners
Odd Lots
1,967 Listeners
Up First from NPR
56,508 Listeners
The Indicator from Planet Money
9,532 Listeners
The Readout Loud
337 Listeners
The Journal.
6,089 Listeners
Short Wave
6,564 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
23 Listeners